Cardlytics/CDLX

$11.80

-4.61%
-
1D1W1MYTD1YMAX

About Cardlytics

Cardlytics, Inc. is a provider of a digital advertising platform. The Company operates an advertising platform within its own and its partners' digital channels, which includes online, mobile applications, email and various real-time notifications (the Cardlytics platform). Through the Cardlytics platform, marketers can deliver advertising content to customers that allows them to earn rewards, which are funded with a portion of the fees it collects from marketers. It maintains the Cardlytics platform in both the United States and the United Kingdom. With the Cardlytics platform, it enables marketers to reach potential customers across its network of financial institutions (FI) partners through their digital banking accounts. It also operates a customer data platform, Bridg platform, which utilizes point-of-sale (POS) data, including product-level purchase data, to enable marketers to perform analytics and targeted loyalty marketing and also measure the impact of their marketing.

Ticker

CDLX

Sector

Technology

Trading on

NASDAQ

Industry

Software & Programming

CEO

Karim Temsamani

Employees

434

Headquarters

Atlanta, United States

Cardlytics Metrics

BasicAdvanced
$606.03M
Market cap
-
P/E ratio
-$3.49
EPS
1.50
Beta
-
Dividend rate
$606.03M
1.49633
$20.52
$4.94
1.78M
1.308
191.084
191.091
-21.29%
-77.77%
-31.87%
1.96
3.708
3.57%
75.13%
18.27%

What the Analysts think about Cardlytics

Analyst Ratings

Majority rating from 3 analysts.
Buy

Price Targets

Average projection from 3 analysts.
49.75% upside
High $18.00
Low $17.00
$11.80
Current price
$17.67
Average price target

Cardlytics Financial Performance

Income StatementBalance sheetCash Flow

Income Statement

Revenues and expenses
-113.13% profit margin
QuarterlyAnnual
Q4 23
QoQ growth
Revenue
$89.1M
12.78%
Net income
$-100.8M
321.76%
Profit margin
-113.13%
273.98%

Cardlytics Earnings Performance

Earnings per share (EPS)

Company profitability
Beat by 16.67%
QuarterlyAnnual
Q1 23
Q2 23
Q3 23
Q4 23
Q1 24
Actual
-$0.25
-$0.24
$0.01
$0.14
-
Expected
-$0.56
-$0.35
-$0.01
$0.12
-$0.11
Surprise
-55.67%
-32.08%
-200%
16.67%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. Fundamental data, financials and analyst ratings are sourced from Refinitiv.

Upcoming events

FAQs

What’s the current market cap for Cardlytics stock?

Cardlytics (CDLX) has a market cap of $606.03M as of April 24, 2024.

What is the P/E ratio for Cardlytics stock?

The price to earnings (P/E) ratio for Cardlytics (CDLX) stock is 0 as of April 24, 2024.

Does Cardlytics stock pay dividends?

No, Cardlytics (CDLX) stock does not pay dividends to its shareholders as of April 24, 2024.

When is the next Cardlytics dividend payment date?

Cardlytics (CDLX) stock does not pay dividends to its shareholders.

What is the beta indicator for Cardlytics?

Cardlytics (CDLX) has a beta rating of 1.5. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.

What is the Cardlytics stock price target?

The target price for Cardlytics (CDLX) stock is $17.67, which is 49.75% above the current price of $11.8. This is an average based on projections from 3 analysts, and represents their view of what the stock price could be in 12 or 18 months. This should not be seen as investment advice - Lightyear does not carry out investment research.

Buy or sell Cardlytics stock

Buy or sell Cardlytics stock

Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.
Start investing